What's in Intech Biopharm Ltd.'s pipeline?

Intech Biopharm Ltd. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Intech Biopharm Ltd.'s portfolio?

Top competitors by shared drug class: California Allergy and Asthma Medical Group, Inc., Chiesi Farmaceutici S.p.A., Dey, Fujian Medical University Union Hospital, GlaxoSmithKline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/intech-biopharm-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Intech Biopharm Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intech Biopharm Ltd. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Budesonide 200 microgram/Puff, HFA MDI	Budesonide 200 microgram/Puff, HFA MDI	marketed	Inhaled corticosteroid	Glucocorticoid receptor	Respiratory

Therapeutic area mix

Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

California Allergy and Asthma Medical Group, Inc. · 1 shared drug class
Chiesi Farmaceutici S.p.A. · 1 shared drug class
Dey · 1 shared drug class
Fujian Medical University Union Hospital · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Imperial College London · 1 shared drug class
Istituto per la Ricerca e l'Innovazione Biomedica · 1 shared drug class
AstraZeneca · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Intech Biopharm Ltd.:

Cite this brief

Drug Landscape (2026). Intech Biopharm Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/intech-biopharm-ltd. Accessed 2026-05-16.